Related Experiment Video
Updated: May 7, 2026

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
A multicenter study of shock pathways for subcutaneous implantable defibrillators
Jürgen Kuschyk1, Goran Milasinovic, Volker Kühlkamp
1Department of Medicine-Cardiology, University Medical Centre, Mannheim, Germany.
Subcutaneous implantable cardioverter-defibrillators (ICDs) can achieve defibrillation efficacy comparable to transvenous systems. Optimized anteroposterior configurations using specific waveforms and electrode placements demonstrate high success rates for lifesaving therapies.
Area of Science:
- Cardiology
- Biomedical Engineering
- Medical Devices
Background:
- Subcutaneous implantable cardioverter-defibrillators (ICDs) offer a potential alternative to transvenous systems.
- Higher energy requirements are a challenge for purely subcutaneous ICDs.
Purpose of the Study:
- To identify anteroposterior subcutaneous shock pathways and waveforms for defibrillation efficacy.
- To achieve efficacy comparable to transvenous implantable cardioverter-defibrillators (ICDs).
Main Methods:
- Defibrillation testing in 141 patients with temporary subcutaneous electrodes.
- Evaluation of different electrode pocket locations (inframammary, infraclavicular) and parasternal additions.
- Assessment of various shock waveforms (750 V/270 μF and 1,000 V/160 μF) at 70 J.
Main Results:
- The IM-1-1000 (93%) and IC-2-1000 (86%) configurations showed the highest success rates (≥50 J).
- The IC-2-750 configuration achieved 44% success, while IM-1-750 achieved 74% and IC-1-750 only 11%.
Conclusions:
- Anteroposterior subcutaneous ICD configurations with 160 μF capacitance and 1,000 V can achieve transvenous-comparable defibrillation efficacy.
- Infraclavicular pocket placement is feasible for subcutaneous ICDs when a parasternal coil is added.
More Related Videos
Related Concept Videos
Cardiopulmonary Resuscitation III: AED Use
Acute Coronary Syndrome III: Diagnostic Studies

